2008, Number 6
<< Back Next >>
Rev Invest Clin 2008; 60 (6)
Osteogenesis of human vascular endothelial cells in culture
Aguilar-Vázquez R, Carballo-Molina OA, Collazo-Navarrete O, Guerrero-Rangel M, Saucedo-Campos AD, Barrera-Lechuga P, López-Marure R, Cáceres-Cortés JR
Language: Spanish
References: 31
Page: 496-501
PDF size: 203.34 Kb.
ABSTRACT
Introduction. Mesenchymal stem cells have the potential to differentiate into several types of cells including osteoblasts. These stem cells have cell surface markers found on cells of endothelial and subendothelial origin of the umbilical cord vein. Taking this into consideration we have postulated that human umbilical vein endothelial cells (HUVEC) could present osteogenic differentiation as well. Gene activation that could drive osteogenic differentiation is regulated by exogenous and endogenous factors.
Objective. The induction osteogenesis in HUVEC.
Material and methods. We used: a) an osteogenic medium containing 0.1
µM dexamethasone, 10
µM β-glycerophosphate, 50
µM L-ascorbic-acid 2-phosphate, 20% MCGS serum; and b) a treatment with DNA demethylating agents hydralazine and 5'-aza-2'-deoxycytidine (0.39-200
µM). Phenotypic characteristics of HUVEC were their spindle and stellate shapes with fine homogenous cytoplasm, typically associated with fibroblast-like cells.
Results. The control cells (without osteogenic treatment) exhibited little extracellular matrix, whereas the osteogenically treated cells appeared shortened and flattened, and they were surrounded by extracellular matrix that subsequently became mineralized
in vitro. After 28 days in culture, morphologic and histochemical stu-dies confirmed that osteogenic medium had a strong stimulatory effect on the alkaline phosphatase activity of endothelial cells, a very early marker of cell differentiation into the osteogenic lineage. Hydralazine and 5'-aza-2'-deoxycytidine, two drugs utilized in chromatin remodeling leading to gene re-expression of inactivated DNA hypermethylated islands, did not favor osteoblast differentiation.
Conclusion. Our study shows that HUVEC can differentiate along an osteogenic li-neage and thus provide an alternative source for cell-based therapies and tissue engineering strategies.
REFERENCES
Lafita J. Physiology and bone physiopathology. An Sist Sanit Navar 2003; 26(Suppl. 3): 7-15.
Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 2006; 98: 538-54.
Shanthly N, Aruva MR, Zhang K, Mathew B, Thakur ML. Stem cells: a regenerative pharmaceutical. Q J Nucl Med Mol Imaging 2006; 50: 205-16.
Park KS, Lee YS, Kang KS. In vitro neuronal and osteogenic differentiation of mesenchymal stem cells from human umbilical cord blood. J Vet Sci 2006; 7: 343-8.
Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-53.
Panepucci RA, Siufi JL, Silva WA Jr, Proto-Siquiera R, Neder L, Orellana M, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004; 22: 1263-78.
Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007; 25: 319-31.
Latham T, Gilbert N, Ramsahoye B. DNA methylation in mouse embryonic stem cells and development. Cell Tissue Res 2008; 331: 31-55.
Barlow DP. Gametic imprinting in mammals. Science 1995; 270: 1610-13.
Goto T, Monk M. Regulation of X-chromosome inactivation in development in mice and humans. Microbiol Mol Biol Rev 1998; 62: 362-78.
Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16: 168-74.
Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 1997; 57: 2229-37.
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994; 91: 9700-04.
Fan G, Martinowich K, Chin MH, He F, Fouse SD, Hutrich L, et al. DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling. Development 2005; 132: 3345-56.
Jüttermann R, Li E, Jaenisch R. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA 1994; 91: 11797-801.
Jones PA, Taylor SM, Mohandas T, Shapiro LJ. Cell cyclespecific reactivation of an inactive X-chromosome locus by 5- azadeoxycytidine. Proc Natl Acad Sci USA 1982; 79: 1215-19.
Jones PA. Altering gene expression with 5-azacytidine. Cell 1985; 40: 485-6.
Haaf T, Schmid M. 5-Azadeoxycytidine induced undercondensation in the giant X chromosomes of Microtus agrestis. Chromosoma 1989; 98: 93-8.
Jablonka E, Goitein R, Marcus M, Cedar H. DNA hypomethylation causes an increase in DNase-I sensitivity and an advance in the time of replication of the entire inactive X chromosome. Chromosoma 1985; 93: 152-6.
Gimbrone MA Jr. Culture of vascular endothelium. In: Spaet TH (ed.). Progress in Hemostasis and Thrombosis. New York: Grune & Stratton; 1976, p. 1-28.
Maciag T, Hoover GA, Stemerman MB, Weinstein R. Serial propagation of human endothelial cells in vitro. J Cell Biol 1981; 91: 420-6.
Thornton SC, Mueller SN, Levine EM. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983; 222: 623-5.
Al-Salihi KA, Samsudin AR. Bone marrow mesenchymal stem cells differentiation and proliferation on the surface of coral implant. Med J Malaysia 2004; 59(Suppl. B): 45-6.
Helman Y, Natale F, Sherrell RM, Lavigne M, Starovoytov V, Gorbunov MY, Falkowski PG. Extracellular matrix production and calcium carbonate precipitation by coral cells in vitro. Proc Natl Acad Sci USA 2008; 105: 54-8.
Welford RW, Schlemminger I, McNeill LA, Hewitson KS, Schofield CJ. The selectivity and inhibition of AlkB. J Biol Chem 2003; 278: 10157-61.
Franceschi RT, Iyer BS, Cui YQ. Effects of ascorbic-acid on collagen matrix formation and osteoblast differentiation in murine Mc3t3–E1 cells. J Bone Miner Res 1994; 9: 843-54.
Peterkofsky B, Udenfriend S. Enzymatic hydroxylation of proline in microsomal polypeptide leading to formation of collagen. Proc Natl Acad Sci USA 1965; 53: 335-42.
Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr 1991; 54: 1135-40.
Murad S, Grove D, Lindberg KA, Reynolds G, Sivarajah A, Pinell SR. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci USA 1981; 78: 2879-82.
Tsuneto M, Yamazaki H, Yoshino M, Yamada T, Hayashi S. Ascorbic acid promotes osteoclastogenesis from embryonic stem cells. Biochem Biophys Res Commun 2005; 335: 1239-46.
Delorme B, Charbord P. Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol Med 2007; 140: 67-81.